Developer of a technology platform for the synthesis of long DNA molecules. Developer of a technology platform for the synthesis of long DNA molecules. The company uses genetic solutions by the high-throughput synthesis of DNA. The company is focusing on libraries of DNAs of lengths of up to thousands of base pairs. The company is building genomes, high-throughput libraries, along with providing new products based on DNA, storing data, computing with DNA, and building DNA-based nanotechnological devices. The company operates in the Life Sciences > Life Sciences Platforms and Tools, Life Sciences > Genomics sector. Founded in 2017 and headquartered in Vienna, Austria and has raised $20.1 million in Series A funding. Key investors include tecnet equity, Austria Wirtschaftsservice, xista, EIC Fund, Hadean Ventures, Lansdowne Partners, Helicase Venture, Europa.
← All startups
Ribbon Biolabs
Series ADeveloper of a technology platform for the synthesis of long DNA molecules. Developer of a technology platform for the synthesis of long DNA molecules. The company uses genetic solutions by the high-throughput synthesis of DNA. The company is focusing on libraries of DNAs of lengths of up to thousands of base pairs. The company is building genomes, high-throughput libraries, along with providing new products based…
About
Business model
Genomics > Applied Genomics > Synthetic Biology,
Life Sciences Platforms and Tools > Research Reagents and Kits > Genomics > Nucleic Acid Synthesis > DNA
Institutional investors
tecnet equityAustria WirtschaftsservicexistaEIC FundHadean VenturesLansdowne PartnersHelicase VentureEuropaStartup Live
Latest coverage
📰 See all funding news — keep up with the raises that set comps.
Investor directory
🗂️ See who's investing in Life Sciences — full fund directory with check size and geography.